Allen Davidoff, PhD

Dr. Allen Davidoff has over 19 years drug development experience) is the founder and CEO of XORTX. Allen has a broad range of clinical and regulatory experience and senior management experience in pharmaceutical R&D including four investigational new drug (“IND”) applications or supplemental IND’s, two phase I studies (four of which were multi-country), eight phase II studies, and one NDA. Prior to co-founding XORTX, Allen was the Chief Scientific Officer, VP Product Development and co-founder of Stem Cell Therapeutics Corp. (seven years) Trillium TRIL:NASDAQ acquired by Pfizer and Senior Scientist and Head of Pharmacology at Cardiome Pharma Corp.